Department of Pharmaceutics, Unaizah College of Pharmacy, Qassim University, Unaizah, Saudi Arabia.
Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
Ann Med. 2023;55(2):2295398. doi: 10.1080/07853890.2023.2295398. Epub 2024 Jan 2.
Brucellosis is a pervasive zoonotic disease caused by various species. It mainly affects livestock and wildlife and poses significant public health threats, especially in regions with suboptimal hygiene, food safety, and veterinary care standards. Human contractions occur by consuming contaminated animal products or interacting with infected animals. This study aims to provide an updated understanding of brucellosis, from its epidemiology and pathogenesis to diagnosis and treatment strategies. It emphasizes the importance of ongoing research, knowledge exchange, and interdisciplinary collaboration for effective disease control and prevention, highlighting its global health implications. Pathogenesis involves intricate interactions between bacteria and the host immune system, resulting in chronic infections characterized by diverse clinical manifestations. The diagnostic process is arduous owing to non-specific symptomatology and sampling challenges, necessitating a fusion of clinical and laboratory evaluations, including blood cultures, serological assays, and molecular methods. Management typically entails multiple antibiotics, although the rise in antibiotic-resistant strains poses a problem. Animal vaccination is a potential strategy to curb the spread of infection, particularly within livestock populations. The study provides insights into the complex pathogenesis of brucellosis, the challenges in its diagnosis, and the management strategies involving antibiotic therapy and animal vaccination. It also highlights the emerging issue of antibiotic-resistant strains. In conclusion, brucellosis is a significant zoonotic disease with implications for public health. Efforts should be directed towards improved diagnostic methods, antibiotic stewardship to combat antibiotic resistance, and developing and implementing effective animal vaccination programs. Interdisciplinary collaboration and ongoing research are crucial for addressing the global health implications of brucellosis.
布鲁氏菌病是一种由多种物种引起的普遍的人畜共患病。它主要影响家畜和野生动物,并对公共卫生构成重大威胁,尤其是在卫生条件、食品安全和兽医保健标准欠佳的地区。人类感染是通过食用受污染的动物产品或与受感染动物接触而发生的。本研究旨在提供对布鲁氏菌病的最新认识,从其流行病学和发病机制到诊断和治疗策略。它强调了持续研究、知识交流和跨学科合作对于有效控制和预防疾病的重要性,突出了其对全球健康的影响。发病机制涉及细菌与宿主免疫系统之间的复杂相互作用,导致慢性感染,其临床症状多种多样。由于非特异性症状和采样挑战,诊断过程艰巨,需要将临床和实验室评估相结合,包括血液培养、血清学检测和分子方法。治疗通常需要多种抗生素,但抗生素耐药菌株的出现是一个问题。动物疫苗接种是遏制感染传播的一种潜在策略,特别是在牲畜群体中。本研究深入了解了布鲁氏菌病的复杂发病机制、诊断方面的挑战以及涉及抗生素治疗和动物疫苗接种的管理策略。它还强调了抗生素耐药菌株的新出现问题。总之,布鲁氏菌病是一种对公共卫生具有重要意义的重要人畜共患病。应致力于改进诊断方法、对抗生素耐药性进行抗生素管理、制定和实施有效的动物疫苗接种计划。跨学科合作和持续研究对于应对布鲁氏菌病的全球健康影响至关重要。